Matrixyl-type Palmitoyl Pentapeptide-4 lyophilized vial from Peptisova manufacturing — cosmetic formulation and OEM raw-material supply. B2B catalog with MOQ and lot docs, not consumer retail.
| Compound | Palmitoyl Pentapeptide-4 (Matrixyl-type) |
|---|---|
| Strength | 10 mg lyophilized vial |
| Purity (typical)(suggested) | HPLC ≥98% on COA |
| Format | Lyophilized vial (catalog) |
| MOQ |
| 10 vials (Track A) |
| Commerce track | Track A MOQ checkout; OEM / private label via RFQ |
|---|
Rows marked suggested are planning bands — confirm with sales before PO.
No. This is a B2B cosmetic peptide raw material (lyophilized vial) for formulators and OEM programs — not a consumer finished good.
Track A catalog typically starts at MOQ 10 vials; HPLC purity is documented on the lot COA (typical band ≥98% — confirm with sales).
Yes. Stock vials ship under Track A; branded artwork, carton, and insert sets are scoped via Track B OEM RFQ on Quote Cart.
Filter the COA Vault by this product slug for sample demo lots, or request the matching production lot COA with your PO / RFQ.